Kidney cancer (renal cell carcinoma)

Kidney cancer (renal cell carcinoma, urothelial cell carcinoma etc) is treated with surgical – partial or radical – nephrectomy. An important role in the management of metastases is played by transcuteneous ablation, both for lung and for liver cases, since 5-year survival rates among patients with metastatic disease remain below 10%, according to relevant research. In this method, a fine needle is inserted transcutaneously – guided by axial tomography – and through the needle the tumour is treated with radiofrequencies (RF ablation) or microwaves (MW ablation) so that controlled destruction is caused by high heat (coagulative necrosis).

Dr Ioannis Dedes has been performing transcutaneous ablation treatments for metastatic focus of kidney cancer, both on the liver and the lungs, with absolute success and safety. The long experience of associate physicians, the excellent material/technical infrastructure, and the hospital staff’s sincere interest for patients warrant a medical procedure with positive results.